These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 9193835)

  • 1. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postrenal transplant hemolytic uremic syndrome/thrombotic microangiopathy: Ahmedabad experience.
    Goplani KR; Vanikar AV; Shah PR; Gumber M; Feroz A; Patel HV; Kasat P; Falodia J; Saboo D; Kaswaan K; Geerish MS; Pandya T; Trivedi HL
    Transplant Proc; 2008 May; 40(4):1114-6. PubMed ID: 18555127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
    Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
    Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.
    Said T; Al-Otaibi T; Al-Wahaib S; Francis I; Nair MP; Halim MA; El-Sayed A; Nampoory MR
    Transplant Proc; 2010 Apr; 42(3):814-6. PubMed ID: 20430179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 8. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
    Ferraris JR; Ramirez JA; Ruiz S; Caletti MG; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
    Pediatr Nephrol; 2002 Oct; 17(10):809-14. PubMed ID: 12376808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
    Candinas D; Keusch G; Schlumpf R; Burger HR; Gmür J; Largiadèr F
    Schweiz Med Wochenschr; 1994 Oct; 124(41):1789-99. PubMed ID: 7973505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
    Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance.
    Kim HC; Park SB; Lee SH; Park KK; Park CH; Cho WH
    Transplant Proc; 1994 Aug; 26(4):2134-5. PubMed ID: 8066696
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
    J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V; Bhaskar S; Baliga PK; Rajagopalan PR
    Clin Transplant; 1997 Aug; 11(4):294-8. PubMed ID: 9267718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy in the early post-renal transplant period.
    Ardalan MR; Shoja MM; Tubbs RS; Etemadi J; Esmaili H; Khosroshahi HT
    Ren Fail; 2008; 30(2):199-203. PubMed ID: 18300121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
    Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
    Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombotic microangiopathy after kidney transplantation].
    Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
    Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.